How to evaluate peptide vendors
Vendor quality checks — Certificates of Analysis, third-party HPLC, endotoxin testing, identity verification, and the red flags that matter most.
Updated May 7, 2026 · 5 min read
A startling amount of what gets attributed to peptide side effects is actually vendor-quality issues — endotoxin contamination, mislabeled identity, wrong concentration. Before you run any peptide, the vendor matters as much as the protocol.
What a Certificate of Analysis is
A Certificate of Analysis (COA) is a third-party lab report that documents the actual contents of a vial. A real COA includes:
- Identity testing (mass spectrometry — does this molecule match the labeled peptide?)
- Purity testing (HPLC — what percent of the vial is the labeled compound vs. impurities?)
- Endotoxin testing (LAL — is bacterial endotoxin below the safe threshold?)
- Sterility testing (for injectable products)
- Test date and batch / lot number linking the COA to the specific vial
A COA without a batch number is decorative. A COA without endotoxin and purity numbers is incomplete. A COA from the vendor's "in-house lab" is not third-party.
The red flags
| Red flag | Why it matters |
|---|---|
| No COA available | You don't know what's in the vial |
| COA is undated or batch number doesn't match | The COA was for a different batch |
| Only one or two test categories shown | Identity + purity is the bare minimum; endotoxin matters for injectables |
| Vendor says "we don't share COAs" | Walk away |
| Prices dramatically below market | Either subsidized loss-leader or low-quality product |
| Vendor sells "FDA-approved peptides" | False — research chems are not FDA-approved |
| No physical address / no business details | Hard to do recourse if something goes wrong |
| Shipping from countries with no enforcement | Customs risk + harder quality verification |
| Reviews exclusively positive | Likely curated; look for places that allow critical reviews |
What "good purity" actually means
Pharmaceutical-grade peptides target 99%+ purity. Research-chemical-grade ranges widely:
| Purity claim | Interpretation |
|---|---|
| Above 99% | Best in research-chem class |
| 98–99% | Acceptable, common from reputable vendors |
| 95–98% | Marginal — some impurities likely active |
| Below 95% | Problematic; impurities can drive side effects |
| Not stated | Treat as unknown |
The 1–5% impurity profile matters — those impurities can be other peptides, manufacturing residues, or breakdown products. They don't always look benign. Higher purity is genuinely meaningful, not just marketing.
Endotoxin — the side-effect culprit
Endotoxin is bacterial cell-wall fragment that survives sterilization. Even small amounts in injected products produce:
- Flu-like reactions
- Fever
- Body aches
- Headaches
- Sometimes severe systemic response
Most "this peptide gave me terrible side effects" reports turn out to be endotoxin-contaminated vials when investigated. Reasonable thresholds:
| Use case | Endotoxin limit |
|---|---|
| Pharmaceutical injectable | Below 0.5 EU/mg (FDA threshold for injectables) |
| Research-chem injectable | Below 5 EU/mg (community-accepted) |
| Topical / not for injection | More lenient |
Vendors that don't test endotoxin or won't share results — assume the worst.
Identity verification
Mass spectrometry on the COA confirms identity — that the molecule is the peptide on the label. Without this:
- A vial labeled "TB-500" may be the full thymosin beta-4 protein (similar but different)
- A vial labeled "BPC-157" may be a different short peptide entirely
- "Ipamorelin" may be a related GHRP with different side-effect profile
Identity errors are the most common cause of "this peptide didn't work like the research described." If the molecule isn't what's on the label, the protocol won't behave as expected.
How to actually check a vendor
A practical sequence:
- Ask for COAs for current batches. A real vendor sends them on request.
- Verify the batch number matches what you'll be shipped.
- Check that COAs include identity, purity, AND endotoxin — all three.
- Confirm the lab on the COA is independent. Look up the lab's website.
- Search the vendor name + "review" beyond their own site — Reddit, Discord, peptide forums, BBB.
- Start with a small order to verify quality before committing to a cycle's worth.
- Save the vials and COAs for at least 6 months in case you need to investigate a side effect later.
Common vendor archetypes
| Type | Typical quality | Risk profile |
|---|---|---|
| Pharmaceutical-grade compounding pharmacy | Very high | Low (when legal) — but BPC-157 is no longer compoundable in US |
| Established research-chem vendor with COAs | Generally good | Moderate — quality batch-to-batch variation possible |
| Newer research-chem vendor with COAs | Variable | Moderate-high — track record matters |
| No-COA vendor | Unknown | High — pass |
| Marketplace listings (eBay, etc.) | Unknown | Very high — pass |
What to do if a side effect shows up
If you experience a side effect that seems disproportionate to dose:
- Stop the peptide.
- Save the vial and any remaining product. Don't discard.
- Document symptoms with timestamps.
- Contact the vendor. Reasonable vendors will replace or refund. Their response is itself a quality signal.
- If you can afford it, send the vial for independent testing. Several labs offer this for $100–200.
- Report to relevant communities. Negative reports from real users help everyone.
The bottom line
Vendor quality is the most-overlooked variable in peptide protocols. A premium peptide from a sketchy vendor is a research-chem; a mid-priced peptide from a vendor with rigorous COAs is closer to pharmaceutical-grade. Pay for the verified product.